Bayer Settles With 30 States Over Withdrawn Drug Baycol

Main Category: Pharma Industry / Biotech Industry
Also Included In: Litigation / Medical Malpractice;  Cholesterol
Article Date: 26 Jan 2007 - 14:00 PDT

Current ratings for:
'Bayer Settles With 30 States Over Withdrawn Drug Baycol'

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


Thirty states on Monday reached an $8 million settlement agreement with Bayer regarding allegations that the drug company failed to adequately warn consumers about risks associated with its cholesterol-reducing drug Baycol, the AP/Winston-Salem Journal (AP/Winston-Salem Journal, 1/24). Connecticut Attorney General Richard Blumenthal (D) said the company learned after introducing Baycol in the U.S. in May 1998 that the drug posed considerably greater health risks than similar drugs, especially when taken in higher doses or in combination with another cholesterol-lowering drug. Bayer informed FDA about the drug's elevated risks but did not sufficiently warn consumers or physicians about potential problems, including a severe and potentially fatal muscle reaction that could cause kidney failure, Blumenthal said. Bayer voluntarily withdrew Baycol from the market in August 2001 (Hartford Courant, 1/24). Bayer has not admitted any wrongdoing but has agreed to register relevant clinical drug trials and study results online (AP/Winston-Salem Journal, 1/24). The company also is prohibited from making false or misleading claims in future marketing and sales of its products. The company must pay $8 million to the 30 states for future consumer protection and enforcement programs. The settlement includes Arizona, Arkansas, California, Connecticut, Delaware, Florida, Idaho, Illinois, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Mississippi, Montana, Nevada, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington and Wisconsin (AP/Chicago Sun-Times, 1/24).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Baycol.


Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Barbara Martin. "Bayer Settles With 30 States Over Withdrawn Drug Baycol." Medical News Today. MediLexicon, Intl., 26 Jan. 2007. Web.
26 May. 2012. <http://www.medicalnewstoday.com/releases/61533.php>

APA
Barbara Martin. (2007, January 26). "Bayer Settles With 30 States Over Withdrawn Drug Baycol." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/61533.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Bayer Settles With 30 States Over Withdrawn Drug Baycol'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »